What do, can and should we learn from models to evaluate potential anticancer agents?
about
Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma.Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia.How can grafted breast cancer models be optimized?Patient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells.Translational pharmacokinetic-pharmacodynamic modeling from nonclinical to clinical development: a case study of anticancer drug, crizotinib.Antitumor efficacy testing in rodents.BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived XenograftsModels for prevention and treatment of cancer: problems vs promises.Drugs for solid cancer: the productivity crisis prompts a rethink.Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission.
P2860
Q33728605-1D53002E-8589-46EF-B983-09E28F0CE7C1Q34797782-7E1802CE-6CA4-432A-839C-E0D068793DB9Q35760911-77635CAE-3EFF-4244-BD01-61D316D96AB7Q35884941-44BE4831-FDBF-4FAA-8803-AC2B231874F5Q36910546-AAAB33AD-AC4B-44CE-A3EC-CC65B2BCFEA4Q37002288-F04294BA-9213-4C70-926D-11A2194C469CQ37056708-8C7CDD94-81CE-44A2-8535-6B01FF041BEAQ37356273-A60F8B57-BE13-49E6-B6D9-A73DD8CAA7EBQ41313977-E40D3EEB-D6A7-472A-BA46-2B8688E2E919Q42852367-AEDFE407-C792-4CF6-ACF6-584DFAD92830
P2860
What do, can and should we learn from models to evaluate potential anticancer agents?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
What do, can and should we learn from models to evaluate potential anticancer agents?
@ast
What do, can and should we learn from models to evaluate potential anticancer agents?
@en
type
label
What do, can and should we learn from models to evaluate potential anticancer agents?
@ast
What do, can and should we learn from models to evaluate potential anticancer agents?
@en
prefLabel
What do, can and should we learn from models to evaluate potential anticancer agents?
@ast
What do, can and should we learn from models to evaluate potential anticancer agents?
@en
P2860
P356
P1433
P1476
What do, can and should we learn from models to evaluate potential anticancer agents?
@en
P2093
Susan A Burchill
P2860
P304
P356
10.2217/14796694.2.2.201
P407
P577
2006-04-01T00:00:00Z